No Prescription |
 |
 | ||
|
Ranolaz Ranexa |
|
| ||
No Prescription » Prescription Drugs 14 » Ranolaz Ranexa Ranolazine is used with other medications to treat angina (chest pain or pressure that is felt when the heart does not get enough oxygen) that is a symptom of an ongoing condition. Ranolazine is used to treat people who still experience angina even when they take other medications to treat the condition. Ranolazine may prevent episodes of angina but it cannot be used to relieve an episode of angina that has already begun. Ranolazine is in a class of medications called anti-ischemics. The exact way that ranolazine works is not known at this time.Ranolazine comes as an extended-release (long-acting) tablet to take by mouth. It is usually taken with or without food two times a day. Take ranolazine at around the same times every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take ranolazine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Swallow the tablets whole; do not break chew or crush them.Your doctor will probably start you on a low dose of ranolazine and gradually increase your dose.Do not take ranolazine to treat a sudden attack of angina. Your doctor will tell you what you should do if you experience an attack of angina. Make sure that you understand these directions.Ranolazine may help to control your condition but will not cure it. Continue to take ranolazine even if you feel well. Do not stop taking ranolazine without talking to your doctor. Buy Ranolaz Ranexa and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About Ranolaz Ranexa: Product Type: Prescription Drugs 14 Ranolaz ( Ranexa Corvela Caroza Generic Ranolazine ) Ranolaz (Ranexa Corvela Caroza Generic Ranolazine) Ranexa Corvela Caroza Generic Ranolazine 500mg Ranexa Corvela Caroza Generic Ranolazine Ranolaz
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
